Oral platelet glycoprotein IIb/IIIa receptor antagonists: the present challenge is safety.
Vorchheimer
D A
DA
Fuster
V
V
D000284:Administration, Oral; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects* / Q000627:therapeutic use; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*
D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex